RT Journal Article
SR Electronic
T1 Cross-sectional cycle threshold values reflect epidemic dynamics of COVID-19 in Madagascar
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.06.21259473
DO 10.1101/2021.07.06.21259473
A1 Andriamandimby, Soa Fy
A1 Brook, Cara E.
A1 Razanazatovo, Norosoa
A1 Rakotondramanga, Jean-Marius
A1 Rasambainarivo, Fidisoa
A1 Raharimanga, Vaomalala
A1 Razanajatovo, Iony Manitra
A1 Mangahasimbola, Reziky
A1 Razafindratsimandresy, Richter
A1 Randrianarisoa, Santatra
A1 Bernardson, Barivola
A1 Rabarison, Joelinotahiana Hasina
A1 Randrianarisoa, Mirella
A1 Nasolo, Frédérick Stanley
A1 Rabetombosoa, Roger Mario
A1 Randremanana, Rindra
A1 Héraud, Jean-Michel
A1 Dussart, Philippe
YR 2021
UL http://medrxiv.org/content/early/2021/07/08/2021.07.06.21259473.abstract
AB As the national reference laboratory for febrile illness in Madagascar, we processed samples from the first epidemic wave of COVID-19, between March and September 2020. We fit generalized additive models to cycle threshold (Ct) value data from our RT-qPCR platform, demonstrating a peak in high viral load, low-Ct value infections temporally coincident with peak epidemic growth rates estimated in real time from publicly-reported incidence data and retrospectively from our own laboratory testing data across three administrative regions. We additionally demonstrate a statistically significant effect of duration of time since infection onset on Ct value, suggesting that Ct value can be used as a biomarker of the stage at which an individual is sampled in the course of an infection trajectory. As an extension, the population-level Ct distribution at a given timepoint can be used to estimate population-level epidemiological dynamics. We illustrate this concept by adopting a recently-developed, nested modeling approach, embedding a within-host viral kinetics model within a population-level Susceptible-Exposed-Infectious-Recovered (SEIR) framework, to mechanistically estimate epidemic growth rates from cross-sectional Ct distributions across three regions in Madagascar. We find that Ct-derived epidemic growth estimates slightly precede those derived from incidence data across the first epidemic wave, suggesting delays in surveillance and case reporting. Our findings indicate that public reporting of Ct values could offer an important resource for epidemiological inference in low surveillance settings, enabling forecasts of impending incidence peaks in regions with limited case reporting.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the US National Institutes of Health [1R01AI29822-01]; the Bill & Melinda Gates Foundation, Seattle, WA [GCE OPP1211841]; and the Innovative Genomics Institute at UC Berkeley, Berkeley, CA [COVID-19 Rapid Response Grant].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical clearance (096-MSANP/CERBM)has been obtained by the "Biomedical research ethics board of the Ministry of Public Health of Madagascar".All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are available.